Rejuvenate Bio Company

Rejuvenate Bio has developed a cardio-protective gene therapy that holds the promise of stopping the progression of MVD. We are preparing to run a pilot study in dogs with MVD.
Technology: Others
Industry: Gene therapy, PharmTech
Headquarters: San Diego, California, United States
Founded Date: 2017
Employees Number: 51-100
Funding Status: Seed
Investors Number: 3
Total Funding: 17.1M
Last Funding Date: Apr 27, 2021
Last Funding Type: Venture

Visit Website
info@rejuvenatebio.com
https://twitter.com/rejuvenatebio
Register and Claim Ownership